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Procairramide (P, n=6) or flecainide (F, n=lO) were used to terminate 
atrial flutter (AF) in a reentry model with a partially refractory 
excitable gap. Plunge wire electrodes were introduced around a 
Y-shape.i incision in the right atrium in 16 pigs (body weight approx. 
32 kg), and 59 sustained AT’s (mean cycle length 171215 ms) were 
induced by programmed stimulation in 14 pigs. Strength-interval curves 
were obtained with 2 ms stimuli to assess excitability. P or F were 
administered until the termination of AF. Flutter cycle length increased 
gradually to 269574 ms after F and to 281233 ms afkr P (not different, 
P versus F). Current thresholds, refractory periods (RP) and conducrion 
velocity al baseline and at termination were: 
baseline prbcaiaamide baseline flecaiaide 
Thresh. (mA) 1.3-cO.8 1.4~0.4 0.7IO.4 12~0.6~ 
Effec. RP(ms) 198215 228116~ 205zX? 201+24 
Absol. RP(ms) 155z18 184t16* 158221 164-c?2 
Cond. (cm/s) 502 7 302 4’ 452 2 282 4. 
ean values 2 SD: + = ~~0.05 versus corresponding baseline value. 
In conclusion, both drugs terminate this subtype of reentry by a 
comparable reduction of the conduction velocity, procainamide by its 
effect on atria1 refractoriness and flecainide by an increase of the 
current threshold and hence by its inhibition of the source of 
propagation. Therefore, this model differentiates class la (procainamide) 
from class Ic (flecainide) antiarrhythmic actSties. 
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